PCMC
BNTX icon

Planning Capital Management Corporation’s BioNTech BNTX Stock Holding History

Planning Capital Management Corporation’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$53.6K Buy
451
+450
+45,000% +$41.4K 0.04% 169
2024
Q2 		$81 Buy
+1
New +$91 ﹤0.01% 672

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Planning Capital Management Corporation's BNTX Position: Q3 2024 in Review

Planning Capital Management Corporation increased its BioNTech (BNTX) stake by 45,000% in Q3 2024, buying an estimated $41.4K and bringing the position to 451 shares worth $53.6K. The position accounts for 0.04% of the portfolio, ranked #169.

Planning Capital Management Corporation first reported a position in BNTX in Q2 2024 and has held it in 2 quarters since. 296 funds tracked by Wall St. Rank hold BNTX as of Q3 2024.

  • Planning Capital Management Corporation held 451 shares of BioNTech worth $53.6K as of Q3 2024.
  • Planning Capital Management Corporation bought 450 BioNTech shares in Q3 2024, an estimated $41.4K.
  • BioNTech made up 0.04% of Planning Capital Management Corporation's portfolio in Q3 2024, its #169 holding.
  • Planning Capital Management Corporation first reported a position in BioNTech in Q2 2024 and has held it in 2 quarters since.
  • 296 funds tracked by Wall St. Rank held BioNTech as of Q3 2024.

Based on Planning Capital Management Corporation's 13F filing for Q3 2024, filed 6 Nov 2024.